blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4255920

EP4255920 - COMPOSITIONS AND METHODS FOR MODULATING CANCER IN NON-HUMAN MAMMALS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.09.2023
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  14.06.2022
Most recent event   Tooltip09.02.2024Change: Validation statespublished on 13.03.2024  [2024/11]
09.02.2024Change - extension statespublished on 13.03.2024  [2024/11]
Applicant(s)For all designated states
Hoffman Technologies LLC
750 Lexington Avenue
9th Floor, Suite 07-103
New York, New York 10022 / US
[2023/41]
Inventor(s)01 / HOFFMAN, Steven
Henderson, Nevada 89052 / US
 [2023/41]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2023/41]
Application number, filing date21901457.802.12.2021
[2023/41]
WO2021US61598
Priority number, dateUS202063120634P02.12.2020         Original published format: US 202063120634 P
[2023/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2022120039
Date:09.06.2022
Language:EN
[2022/23]
Type: A2 Application without search report 
No.:EP4255920
Date:11.10.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 09.06.2022 takes the place of the publication of the European patent application.
[2023/41]
Search report(s)International search report - published on:US18.08.2022
ClassificationIPC:C07K14/47, C07K14/705, C07K14/71
[2023/41]
CPC:
A61K31/198 (EP,US); A61K31/568 (EP,US); A61K31/195 (EP);
A61K31/37 (EP); A61K31/407 (EP,US); A61K31/4166 (US);
A61K31/436 (EP); A61K38/12 (US); A61P35/00 (US) (-)
C-Set:
A61K31/195, A61K2300/00 (EP);
A61K31/198, A61K2300/00 (EP);
A61K31/37, A61K2300/00 (EP);
A61K31/407, A61K2300/00 (EP);
A61K31/436, A61K2300/00 (EP);
A61K31/568, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/41]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION VON KREBS BEI NICHTMENSCHLICHEN SÄUGERN[2023/41]
English:COMPOSITIONS AND METHODS FOR MODULATING CANCER IN NON-HUMAN MAMMALS[2023/41]
French:COMPOSITIONS ET MÉTHODES DE MODULATION D'UN CANCER CHEZ DES MAMMIFÈRES NON HUMAINS[2023/41]
Entry into regional phase30.06.2023National basic fee paid 
30.06.2023Search fee paid 
30.06.2023Designation fee(s) paid 
30.06.2023Examination fee paid 
Examination procedure30.06.2023Examination requested  [2023/41]
26.01.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
07.02.2024Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.12.202303   M06   Fee paid on   07.02.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2009247731  (ADAMS JULIAN [US], et al);
 [A]WO2013109610  (HOFFMAN STEVEN [US]);
 [A]US2019380995  (BARANOWITZ STEVEN [US]);
 [YA]US2020215082  (HOFFMAN STEVEN [US]);
 [XYA]US2020360328  (HOFFMAN STEVEN [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.